Word

BIOSKRYB GENOMICS

Status

Pending

Status Code

731

Status Date

Monday, January 8, 2024

Serial Number

90466612

Mark Type

4000

Filing Date

Thursday, January 14, 2021

Published for Opposition

Tuesday, November 22, 2022

Trademark Owner History

BIOSKRYB GENOMICS, INC. - Owner At Publication
BioSkryb, Inc. - Original Applicant

Classifications

9 Downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi-omics data; downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; downloadable computer software for medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; downloadable computer software for nucleic acid and ribonucleic acid analysis for medical and scientific research purposes; downloadable computer software for providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; downloadable computer software for medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; downloadable computer software for medical and scientific research in connection with genome amplification to detect genetic variants in cells; downloadable computer software for medical and scientific research in connection with measuring genetic diversity in single cells; downloadable computer software for medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; downloadable computer software for medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; downloadable computer software for DNA analysis and sequencing for scientific, medical, and research purposes; downloadable computer software for research, development and consultancy in the field of genomics; downloadable computer software for compiling data for research purposes in the field of genomics; downloadable computer software for providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; downloadable computer software for medical testing, diagnosis, and treatment; downloadable computer software for bioinformatic DNA sequencing analysis for biomarker discovery and annotation for use in connection with offering medical analysis services for diagnostic and treatment purposes provided by medical laboratories; downloadable computer software for medical diagnostic testing, monitoring, and reporting; downloadable computer software for medical analysis and diagnosis in connection with the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; downloadable computer software for medical analysis and diagnosis in the field of gene therapy and cell therapy; downloadable computer software for medical analysis and diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific and laboratory apparatus and instruments, namely, magnetic plates for use with magnetic and paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits containing a scientific or laboratory apparatus or instrument, namely, kits comprising multi-well plates, magnetic plates, and reagents comprising paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits comprising a scientific or laboratory apparatus or instrument for the amplification and recovery of genomic material, including genomic material from single cells, and reagents for scientific or research use; scientific and laboratory apparatus and instruments, namely, a thermal mixer and plate spinner for the amplification and recovery of genomic material not for medical use; kits containing scientific apparatus, namely, a thermal mixer and plate spinner for use in genetic research; scientific and laboratory apparatus and instruments, namely, a thermal mixer and plate spinner for the amplification and recovery of genomic material not for medical use; kits containing scientific apparatus, namely, a thermal mixer and plate spinner for use in genetic research; scientific and laboratory apparatus and instruments, namely, a thermal mixer and plate spinner for the amplification and recovery of genomic material not for medical use; kits containing scientific apparatus, namely, a thermal mixer and plate spinner for use in genetic research

5 Diagnostic reagents for medical use; reagents and containers specifically adapted for reagents, namely, reagents comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells, for medical purposes; diagnostic chemical test kits consisting primarily of monoclonal antibodies, buffers, and reagents for medical use; medical test kits comprised of medical diagnostic reagents and assays for high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; medical test kits comprised of medical diagnostic reagents for use in the amplification and recovery of genomic material, including genomic material from single cells; kits comprising reagents, namely, reagents for medical use comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits comprised of cells and biological tissue sample specimens for diagnostic purposes for medical use; diagnostic kits comprising reagents for medical use

1 Assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; diagnostic reagents for clinical or medical laboratory use; reagents for scientific use; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; reagents for scientific use for use in kits for high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; reagents and containers specifically adapted for reagents, namely, reagents comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells, for research purposes; reagents and containers specifically adapted for reagents, namely, reagents for scientific use for use in the amplification and recovery of genomic material, including genomic material from single cells; chemical substances and products, namely, chemical preparations for use in genomic research; biochemicals, namely, biological reagents for use in whole genome amplification to detect genetic variants in each cell for non-medical purposes; laboratory chemicals, namely, an antibody reagent used for genomic research; chemical test kits for diagnostic purposes for laboratory and research use; diagnostic kits comprising reagents for scientific use; diagnostic kits comprised of reagents and assays for scientific use for detecting, testing, analyzing, and sequencing genes, nucleic acids, and biological molecules; medical test kits comprised of reagents for scientific use for biological analysis for use in whole genome amplification to detect genetic variants in cells; kits comprising reagents, namely, reagents for scientific use comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits containing assays, reagents, and chemical preparation for use in genomic research; kits containing biochemicals, namely, biological reagents for scientific use for use in whole genome amplification to detect genetic variants in each cell; kits comprised of cells and biological tissue sample specimens for diagnostic purposes for laboratory or research use; laboratory apparatus and instruments, namely, chemical genomic testing kits; kits containing laboratory chemicals, namely, antibody reagents used for genomic research

44 Medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing, monitoring and reporting services; medical analysis services for diagnosis the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; medical analysis services for diagnosis in the field of gene therapy and cell therapy; medical analysis services for diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics

10 Gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical and scientific purposes; medical apparatus and instruments, namely, a thermal mixer and plate spinner for the amplification and recovery of genomic material for medical purposes; medical apparatus and instruments, namely, magnetic plates for use with magnetic and paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells

42 Genomic analysis and sequencing services for scientific, medical, and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; nucleic acid and ribonucleic acid analysis services for medical and scientific research purposes; providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; medical and scientific research in connection with genome amplification to detect genetic variants in cells; medical and scientific research in connection with measuring genetic diversity in single cells; medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; DNA analysis and sequencing services for scientific, medical, and research purposes; research, development and scientific consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi-omics data; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; providing temporary use of non-downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for nucleic acid and ribonucleic acid analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; providing temporary use of non-downloadable computer software for medical and scientific research in connection with genome amplification to detect genetic variants in cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with measuring genetic diversity in single cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; providing temporary use of non-downloadable computer software for medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; providing temporary use of non-downloadable computer software for DNA analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for biomarker discovery and annotation for use in connection with offering medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing temporary use of non-downloadable computer software for use in connection with medical diagnostic testing, monitoring, and reporting; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in connection with the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of gene therapy and cell therapy; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics

BIO SKRYB GENOMICS; BIO SCRIBE GENOMICS
"GENOMICS"

Trademark Events

Jan 10, 2024

Notice Of Approval Of Extension Request E-Mailed

Jan 8, 2024

Sou Extension 2 Granted

Jan 8, 2024

Sou Extension 2 Filed

Jan 8, 2024

Sou Teas Extension Received

Jul 7, 2023

Notice Of Approval Of Extension Request E-Mailed

Jul 5, 2023

Sou Extension 1 Granted

Jul 5, 2023

Sou Extension 1 Filed

Jul 5, 2023

Sou Teas Extension Received

Jan 17, 2023

Noa E-Mailed - Sou Required From Applicant

Nov 22, 2022

Official Gazette Publication Confirmation E-Mailed

Nov 22, 2022

Published For Opposition

Nov 2, 2022

Notification Of Notice Of Publication E-Mailed

Oct 17, 2022

Approved For Pub - Principal Register

Oct 17, 2022

Examiner's Amendment Entered

Oct 17, 2022

Notification Of Examiners Amendment E-Mailed

Oct 17, 2022

Examiners Amendment E-Mailed

Oct 17, 2022

Examiners Amendment -Written

Sep 2, 2022

Notification Of Examiner's Amendment/Priority Action E-Mailed

Sep 2, 2022

Examiner's Amendment/Priority Action E-Mailed

Sep 2, 2022

Combined Examiner's Amendment/Priority Action Automatic Entry

Sep 2, 2022

Examiners Amendment And/Or Priority Action - Completed

Aug 19, 2022

Notification Of Subsequent Final Emailed

Aug 19, 2022

Continuation Of Final Refusal E-Mailed

Aug 19, 2022

Action Continuing A Final - Completed

Jul 28, 2022

Teas/Email Correspondence Entered

Jul 27, 2022

Correspondence Received In Law Office

Jul 27, 2022

Teas Request For Reconsideration Received

Feb 2, 2022

Notification Of Final Refusal Emailed

Feb 2, 2022

Final Refusal E-Mailed

Feb 2, 2022

Final Refusal Written

Feb 1, 2022

Teas/Email Correspondence Entered

Feb 1, 2022

Correspondence Received In Law Office

Feb 1, 2022

Teas Response To Office Action Received

Sep 17, 2021

Applicant/Correspondence Changes (Non-Responsive) Entered

Sep 17, 2021

Teas Change Of Correspondence Received

Sep 17, 2021

Teas Change Of Owner Address Received

Aug 2, 2021

Notification Of Non-Final Action E-Mailed

Aug 2, 2021

Non-Final Action E-Mailed

Aug 2, 2021

Non-Final Action Written

Jul 26, 2021

Assigned To Examiner

Jun 2, 2021

Automatic Update Of Assignment Of Ownership

Apr 15, 2021

New Application Office Supplied Data Entered

Jan 18, 2021

New Application Entered